Researchers developed a tool for predicting the prognosis of people with chronic lung disease-related pulmonary hypertension.

Pulmonary hypertension (PH) risk grows over time for patients with narrowing of the aorta, the body's biggest blood vessel, ...

Corsair Pharma is planning a Phase 1 clinical trial of its treprostinil skin patch as a treatment for pulmonary arterial hypertension (PAH).

Columnist Jen Cueva has gotten more adept at listening to her body and making adjustments to manage her PH and leave room for joy.